Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

saxagliptin 5 MG Oral Tablet [Onglyza]

Known as: Onglyza (as saxagliptin hydrochloride 5.58 MG) 5 MG Oral Tablet, onglyza 5 MG Oral Tablet, saxagliptin hydrochloride 5 mg ORAL TABLET, FILM COATED [ONGLYZA] 
 
National Institutes of Health

Related topics

Related topics

8 relations
Croscarmellose SodiumLactose MonohydrateMagnesium stearateOnglyza
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Saxagliptin: A Review in Type 2 Diabetes
Saxagliptin (Onglyza®) is a highly potent, reversible, competitive dipeptidyl peptidase-4 inhibitor indicated for the treatment… Expand
  • table 1
  • table 2
  • table 3
2015
2015
Of the Big Daddy, the Underdog, the Mother Hen, and the Scapegoats: Balancing Pharmaceutical Innovation and Access to Healthcare in the Enforcement of Compulsory Patent Licensing in India, its…
 
2014
2014
Saxagliptin: a guide to its use in type 2 diabetes mellitus
Oral saxagliptin (Onglyza®), a potent, selective dipeptidyl pepitase-4 inhibitor, is a useful option to improve glycaemic control… Expand
2012
2012
Cost-effectiveness of saxagliptin (Onglyza®) in type 2 diabetes in Sweden.
AIM The objective of this study was to investigate the cost-effectiveness of saxagliptin (Onglyza(®)), a DPP-4 inhibitor, plus… Expand
Review
2012
Review
2012
Saxagliptin: a review of its use as combination therapy in the management of type 2 diabetes mellitus in the EU.
  • L. Yang
  • Drugs
  • 2012
    • Corpus ID: 195687875
Saxagliptin (Onglyza™) is a dipeptidyl peptidase 4 inhibitor widely approved for the treatment of type 2 diabetes mellitus. In… Expand
2012
2012
Liquid chromatography and tandem mass spectrometry method for the quantitative determination of saxagliptin and its major pharmacologically active 5-monohydroxy metabolite in human plasma: method…
A liquid chromatography and tandem mass spectrometry (LC-MS/MS) method was developed and validated to simultaneously determine… Expand
2012
2012
Effect of saxagliptin on the pharmacokinetics of the active components of Ortho‐Cyclen®, a combined oral contraceptive containing ethinyl estradiol and norgestimate, in healthy women
Saxagliptin (Onglyza™) is a dipeptidyl peptidase‐4 (DPP4) inhibitor for treating type 2 diabetes mellitus. This open‐label… Expand
2012
2012
PDB53 Cost-Effectiveness of Saxagliptin (Onglyza®) in Type 2 Diabetes in South Africa
 
2010
2010
Saxagliptin for type 2 diabetes
  • A. Chacra
  • Diabetes, metabolic syndrome and obesity…
  • 2010
    • Corpus ID: 31343898
Saxagliptin (Onglyza™) is a potent, selective, once-daily dipeptidyl peptidase-4 (DPP-4) inhibitor indicated for improving… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
2010
2010
La saxagliptine (Onglyza®) - un nouvel inhibiteur de la DPP-4 pour le traitement oral du diabète de type 2
• L'enzyme DPP-4 degrade physiologiquement les incretines GLP-1 et GIP. • La saxagliptine (Onglyza ® ) est un inhibiteur oral de… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE